StockData
TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW

Tevogen Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$6.77−0.30 (-4.24%)

Close on Oct 19, 2026

Market cap
$25.92M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2024
Ended Mar 31, 2024
Apr 26, 2024Before market open–––

Press releases

Announcements Tevogen filed with the SEC